The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of nivolumab (N) plus ipilimumab (I) in radioidine refractory differentiated thyroid cancer (RAIR DTC) with exploratory cohorts in anaplastic (ATC) and medullary thyroid cancer (MTC).
 
Jochen H. Lorch
Consulting or Advisory Role - Bayer; Eisai; Genentech
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Millennium (Inst); Novartis (Inst)
 
Justine A. Barletta
No Relationships to Disclose
 
Matthew Nehs
No Relationships to Disclose
 
Ravindra Uppaluri
Consulting or Advisory Role - Merck
Research Funding - Merck
 
Erik K. Alexander
No Relationships to Disclose
 
Robert I. Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech; GlaxoSmithKline; Immunomic Therapeutics; Loxo; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Kura Oncology (Inst); Merck (Inst); Pfizer (Inst); VentiRx (Inst)
 
Glenn J. Hanna
Honoraria - Bristol-Myers Squibb; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Maverick Therapeutics; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Exicure (Inst); Kartos Therapeutics (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Maverick Therapeutics; Regeneron
 
Danielle Nina Margalit
No Relationships to Disclose
 
Roy B. Tishler
Consulting or Advisory Role - Regeneron
Other Relationship - Psi Oragenics
 
Jonathan Daniel Schoenfeld
Consulting or Advisory Role - ACI Clinical; Catenion; Debiopharm Group; Immunitas; LEK; Tilos Therapeutics
Research Funding - Bristol-Myers Squibb; Merck; Regeneron
Expert Testimony - Heidell, Pittoni, Murphy & Bach; Kline & Specter P.C.
 
Laura A Goguen
No Relationships to Disclose
 
Azad Jabiev
No Relationships to Disclose
 
Meredith J Sorensen
No Relationships to Disclose
 
Sara Ahmadi
No Relationships to Disclose
 
Ellen Marqusee
No Relationships to Disclose
 
Matthew I Kim
No Relationships to Disclose
 
Darren Stanizzi
No Relationships to Disclose
 
Ethan Harris
No Relationships to Disclose
 
Alec Kacew
No Relationships to Disclose
 
David Allen Barbie
Leadership - XSphera Biosciences
Stock and Other Ownership Interests - XSphera Biosciences
Consulting or Advisory Role - Quiagen; Tango Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst)